Evaluation of the PFA-100® system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease

Thrombosis and Haemostasis

Volumn 82, Issue 1, 1999, Pages 35-39

  Cattaneo, Marco ^a,b   Federici, Augusto B ^a   Lecchi, Anna ^a   Agati, Barbara ^a   Lombardi, Rossana ^a   Stabile, Federica ^a   Bucciarelli, Paolo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Hemophilia and Thrombosis Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; BLOOD CLOTTING FACTOR 8 CONCENTRATE; COLLAGEN; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING TIME; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SCHOOL CHILD; SHEAR STRESS; THROMBOCYTE; VON WILLEBRAND DISEASE;

EID: 0032773694     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614626     Document Type: Article

References (19)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
2. Miller CH, Lenzi R, Breen C. Prevalence of vor Willebrand's disease among US adults. Blood 1987; 70: 377-83.
3. Cattaneo M, Federici AB, Mannucci PM. Diagnosis and treatment of von Willebrand's disease. Int J Red Hematol/Oncol 1994; 1: 499-508.
4. Wagner DD. The Weibel-Palade Body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost 1993; 70: 105-10.
5. Meyer D, Girma JP. von Willebrand factor: Structure and function. Thromb Haemost 1993; 70: 99-104.
6. Ruggeri ZM. von Willebrand factor. J Clin Invest 1997; 99: 559-64.
7. 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267: 11300-6.
8. Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352-61.
9. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
10. Mannucci PM, Lombardi R, Castaman G, Dent JA, Lattuada A, Rodeghiero F, Zimmerman TS. von Willebrand disease ""Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers. Blood 1988; 71: 65-70.
11. O'Brien JR, Salmon GP. Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's Disease. Blood 1987; 70: 1354-61.
12. Pareti FI, Cattaneo M, Carpinelli L, Zighetti ML, Bressi C, Mannucci PM, Ruggeri ZM. Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test. Thromb Haemost 1996; 75: 460-8.
13. Kundu SK, Heilmann E, Sio R, Garcia C, Ostgaart R. Characterization of an in vitro platelet function analyzer. PFA-100™. Clin Appl Thromb Hemost 1996; 2: 2419.
14. Fressinaud E, Veyradiers A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998; 91: 1325-31.
15. Federici AB, Stabile F, Castaman G, Canciani MT, Mannucci PM. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood 1998; 92: 2707-11.
16. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an "in vitro" platelet function analyzer-PFA-100™. Sem Thromb Hemost 1995; 21: 106-12.
17. Mammen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100™ system. Sem Thromb Hemost 1995; 21: 113-21.
18. Italian Working Group. Spectrum of von Willebrand's disease: A study of 100 cases. Br J Haematol 1977; 35: 101-12.
19. Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y. Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand disease. Blood 1986; 68: 58-61.